Mariam Eatedali on Medicare Advantage

Washington Healthcare Update - March 2020 #2

This week in Washington: CMS develops additional code for coronavirus lab tests, announces actions to address spread of coronavirus; House passes bill to ban e-cigarette flavors; Grassley says updated Senate Finance drug...more

3/10/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Drug Pricing , E-Cigarettes , Food and Drug Administration (FDA) , GAO , Medicare Advantage , Medicare Part D , Pharmaceutical Industry

Washington Healthcare Update - March 2020 #1

This week in Washington: Hearings scheduled on the U.S. response to the Coronavirus. ...more

3/3/2020 / Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicaid , Medicare , Medicare Advantage , Pharmaceutical Industry

Washington Healthcare Update - February 2020 #4

Upcoming Hearings/Markups - Wednesday, February 26, 2020 - House Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies: “Department of Health and Human Services...more

2/25/2020 / Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Medicare , Medicare Advantage , Medicare Part D , Prescription Drugs

Washington Healthcare Update - February 2020 #3

This week in Washington: The House and Senate will be in recess the week of Feb. 17 in observation of Presidents Day....more

2/18/2020 / Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Controlled Substances , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , HRSA , Medicaid , Medicare , Medicare Advantage , Medicare Part D , Trump Administration

Washington Healthcare Update - February 2020 #1

This week in Washington: The House of Representatives passes legislation on fentanyl analogues; Senate continues impeachment trial....more

2/4/2020 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , HRSA , Medicare Advantage , Trump Administration

Washington Healthcare Update - January 2020 #3

This week in Washington: The House is not in session. The Senate will resume the impeachment trial on Tuesday....more

1/22/2020 / Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Drug Pricing , Food and Drug Administration (FDA) , HRSA , MACPAC , Medicare , Medicare Advantage , Pharmaceutical Industry , Trump Administration , United States-Mexico-Canada Agreement (USMCA)

Washington Healthcare Update February 2019 #4

Upcoming Hearings - Tuesday, Feb. 26, 2019 - Senate Finance Committee: “Drug Pricing in America: A Prescription for Change, Part II” - The second hearing in a series on drug pricing in the Senate Finance Committee...more

2/26/2019 / Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , HELP , Medicare Advantage , Medicare Part D , OMB , Pharmaceutical Industry , Prescription Drugs , Proposed Rules , Vaccinations

Washington Healthcare Update February 2019 #1

Coming Week’s Highlights: State of the Union scheduled for Feb. 5; House committees continue discussion on pre-existing conditions....more

2/5/2019 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Congressional Budget Office , Department of Health and Human Services (HHS) , Drug Pricing , GAO , Medicare , Medicare Advantage , Medicare Part D , Pharmaceutical Industry , Pharmacy Benefit Manager (PBM) , Prescription Drugs , Section 340B

Mariam Eatedali

McGuireWoods LLP

Popular Topics by This Author

Latest Posts › Medicare Advantage